Journal of Diabetes Research / 2015 / Article / Tab 3

Research Article

Relationship between Serum 25-Hydroxyvitamin D and Lower Extremity Arterial Disease in Type 2 Diabetes Mellitus Patients and the Analysis of the Intervention of Vitamin D

Table 3

The comparison of characteristics before and after treatment in Groups DM3 and DM4.

VariableGroup DM4 ()Group DM3 ()
0 w12 w-value 0 w12 w-value

TC (mmol/L)5.12 ± 0.435.25 ± 0.32−0.13 ± 0.475.17 ± 0.415.3 ± 0.38−0.13 ± 0.5
TG (mmol/L)2.47 ± 0.352.33 ± 0.19b−0.14 ± 0.382.47 ± 0.402.50 ± 0.32−0.03 ± 0.52
LDL (mmol/L)3.18 ± 0.722.43 ± 0.41a,b−0.72 ± 0.852.91 ± 0.733.03 ± 0.60−0.12 ± 1.00
HDL (mmol/L)1.12 ± 0.111.09 ± 0.26−0.03 ± 0.271.11 ± 0.121.19 ± 0.21−0.08 ± 0.25
25(OH)D (ng/mL)12.39 ± 8.3719.27 ± 2.33a,b−6.89 ± 9.03b13.30 ± 7.7611.66 ± 2.371.63 ± 7.63
RBP4 (μg/mL)39.09 ± 2.3225.33 ± 1.68a,b13.76 ± 3.20b39.02 ± 1.9735.44 ± 2.17a3.58 ± 3.05
BMI (kg/m2)25.05 ± 3.3023.95 ± 2.811.10 ± 4.1124.09 ± 3.7723.71 ± 2.850.38 ± 4.65
HbA1c (%)7.38 ± 0.655.95 ± 0.48a,b1.43 ± 0.87b7.35 ± 0.786.74 ± 0.59a0.61 ± 0.92
WHR0.87 ± 0.040.87 ± 0.040.00 ± 0.050.87 ± 0.040.86 ± 0.030.01 ± 0.05

Note: comparison within the group, a; comparison between two groups, b.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.